# Telehealth Marketing Compliance: State Licensure, Prescribing Rules, and the Cross-Border Framework Every Telehealth Practice Needs

Telehealth practices face state-by-state licensure rules, specific prescribing restrictions, controlled-substance considerations, and cross-border marketing compliance. Here's the framework for telehealth marketing.

By RegenCompliance Editorial (FDA/FTC compliance desk). Published 2025-12-19. Reading time 8 minutes.
Canonical page: https://regencompliance.ai/blog/telehealth-marketing-compliance-overview

Telehealth has grown from a niche delivery mode to a dominant healthcare category in several specialties - mental health, weight loss, primary care, hormone therapy, dermatology. The marketing compliance framework for telehealth combines standard healthcare marketing rules with telehealth-specific considerations: state-by-state licensure, Ryan Haight Act prescribing rules, cross-border marketing rules, and specific state AG enforcement patterns. This post covers the framework.

## State licensure and marketing

Telehealth practices must be licensed in the states where their patients are located. For marketing:

- Marketing to patients in a state where the practice’s providers aren’t licensed is a consumer-protection issue and potentially a licensure violation.
- Marketing should accurately represent in which states services are available.
- “Available nationwide” marketing is misleading if the practice isn’t licensed everywhere.
- State AGs have pursued telehealth practices for marketing to their state residents without appropriate licensure.

## Ryan Haight Act and controlled substances

The Ryan Haight Online Pharmacy Consumer Protection Act restricts online prescribing of controlled substances. Telehealth controlled-substance prescribing has been in regulatory flux, with DEA issuing multiple guidance updates. Marketing considerations:

- Telehealth prescribing of Schedule II-V controlled substances (including ADHD medications, benzodiazepines, buprenorphine for OUD, testosterone, ketamine) faces specific Ryan Haight considerations.
- Marketing that implies easy access to controlled substances through telehealth has drawn DEA and state board attention.
- Current DEA rules and flexibilities change; marketing should reflect current framework.

## Common telehealth marketing patterns that draw enforcement

### Pattern 1: “Skip the doctor visit” framing

Marketing that minimizes the clinical evaluation step has drawn state medical board and state AG attention. Compliant marketing frames the telehealth visit as a legitimate medical encounter, not as an alternative to medical care.

### Pattern 2: “24-hour script” speed marketing

Speed-of-prescription marketing has been specifically criticized for implying inadequate clinical evaluation. State medical boards have cited this language pattern in enforcement.

### Pattern 3: Asynchronous vs synchronous misrepresentation

Asynchronous (store-and-forward) and synchronous (real-time video) telehealth have different regulatory status in different states. Marketing should accurately represent the actual service model.

### Pattern 4: Licensure status implications

Marketing that implies broader licensure than actually held (e.g., “our doctors can treat you anywhere” when they’re licensed in specific states) creates consumer-protection exposure.

### Pattern 5: Specialty-implying language

Telehealth specialty marketing (“our dermatologists,” “our psychiatrists”) should accurately reflect actual specialist credentialing, not general practitioner services marketed under specialist framing.

## State-specific enforcement focus

Several states have been particularly active on telehealth marketing. The [FTC Health Products Compliance Guidance](https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance) and [FTC health claims standards](https://www.ftc.gov/business-guidance/advertising-marketing/health-claims) apply alongside state-level enforcement:

- **Texas.** Texas Medical Board on telehealth prescribing practices; Texas AG under DTPA.
- **California.** Medical Board of California on supervision and prescribing; AG under B&P 17500.
- **New York.** OPMC on prescribing and corporate practice; AG under Executive Law 63(12).
- **Florida.** Florida Board of Medicine plus FDUTPA enforcement.

## Category-specific telehealth marketing

### Mental health telehealth

See [mental health practice marketing compliance](https://regencompliance.ai/blog/mental-health-practice-marketing-compliance). Add telehealth-specific licensure, HIPAA sensitivity, and Ryan Haight considerations for psychiatric prescribing.

### Weight loss / GLP-1 telehealth

See [GLP-1 and semaglutide marketing compliance](https://regencompliance.ai/blog/glp-1-semaglutide-marketing-compliance). Compounded GLP-1 marketing plus telehealth prescribing considerations stack.

### Dermatology telehealth

See [dermatology marketing compliance](https://regencompliance.ai/blog/dermatology-marketing-compliance). Add store-and-forward vs synchronous rules, state-specific teledermatology rules.

### Hormone therapy telehealth

See [hormone replacement therapy marketing compliance](https://regencompliance.ai/blog/hormone-replacement-therapy-marketing-compliance). Add Ryan Haight considerations for testosterone prescribing, state-specific rules on telehealth hormone prescribing.

### Primary care telehealth

Standard primary care rules plus telehealth framework. Marketing should accurately represent the scope of services available through telehealth vs in-person.

## Compliant telehealth marketing framework

- **Accurate licensure representation.**Specific states where services are available, specific service limitations, specific provider credentialing.
- **Clinical evaluation emphasis.** Frame telehealth visits as legitimate medical encounters with appropriate evaluation, not as convenience shortcuts.
- **Clear service model description.**Synchronous vs asynchronous, what’s included, what requires in-person referral.
- **Specific pricing disclosure.** What’s included in quoted pricing, what’s additional.
- **Conservative prescribing marketing.**Especially for controlled substances; avoid speed-focused framing.

## Frequently asked questions

### Can I market telehealth services to patients in states where I'm not licensed?

Generally no. State AGs have pursued practices that marketed to state residents without appropriate licensure. Geographic targeting of marketing should match your licensure.

### How do I handle multi-state telehealth practice marketing?

List specific states where services are available. If services vary by state (some services in some states, all in others), accurately represent that variation.

### What are current Ryan Haight Act rules?

This is in active regulatory flux. DEA has issued multiple guidance updates. Current rules should be verified with healthcare regulatory counsel familiar with telehealth controlled-substance prescribing.

### Are there specific rules on telehealth asynchronous care marketing?

Yes, varying by state. Some states require synchronous evaluation for prescribing; some allow asynchronous. Marketing should accurately reflect the allowed service model in each state served.

### What about HIPAA considerations specific to telehealth?

Platform selection (HIPAA-compliant telehealth platforms), patient communication channels, and data security considerations all affect HIPAA posture. Marketing that makes security claims should reflect actual practices.

### How do I stay current on telehealth rule changes?

Subscribe to state medical board updates, monitor DEA guidance, track state-specific telehealth rule changes. Healthcare regulatory counsel with telehealth expertise is essential for practices in this category.

Key Takeaways

- Telehealth marketing must reflect state-by-state licensure accurately - marketing to state residents where providers aren't licensed is an enforcement pattern.
- Ryan Haight Act restrictions on online controlled-substance prescribing are in active flux; marketing should reflect current rules.
- 'Skip the doctor visit' and speed-focused framing has drawn specific state medical board enforcement.
- Telehealth marketing varies significantly by category - mental health, weight loss, hormone therapy, and dermatology each have specific considerations.
- Texas, California, New York, and Florida have been notably active on telehealth marketing enforcement.

---

RegenCompliance is FDA/FTC compliance scanning software for healthcare marketing, operated by Regen Portal LLC. Educational compliance tool, not legal advice. Not affiliated with the FDA or FTC. Contact: support@regencompliance.ai. Full site index for AI agents: https://regencompliance.ai/llms.txt